Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP US
Sizing up the future
What role will individually tailored therapies play in the pharmaceutical industry’s new business models?01 Oct 2009
Focus Area: Drug Discovery
Peptide microarrays in protein kinase and nuclear receptor research
Dr Rob Ruijtenbeek, VP Biological Sciences, PamGene International BV, Nieuwstraat 30,
5211NL ‘s-Hertogenbosch, The Netherlands
Asterand PhaseZERO - a solution for Drug Development
By Robert A Coleman, PhD, Asterand plc
The New Pharma Landscape
The pharmaceutical industry has found itself beset by problems in recent years, not least the slowing of the blockbuster model. How can the sector shake off its lethargy? By Neil Davey
It’s All in the Genes
Frances Davies looks at why the genomics revolution is transforming modern medicine. Genetics and its successor genomics is currently one of the most hotly tipped scientific fields, with an enormous potential to revolutionize medicine and provide new therapeutic treatment for diseases.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.